Feng Chi Biotech (ROCO:6744) Revenue per Share : NT$11.68 (TTM As of Dec. 2023)

View and export this data going back to 2019. Start your Free Trial

What is Feng Chi Biotech Revenue per Share?

Feng Chi Biotech's revenue per share for the six months ended in Dec. 2023 was NT$5.57. Feng Chi Biotech's revenue per share for the trailing twelve months (TTM) ended in Dec. 2023 was NT$11.68.

Warning Sign:

Feng Chi Biotech Corp revenue per share is in decline over the past 12 months.

During the past 12 months, the average Revenue Per Share Growth Rate of Feng Chi Biotech was -7.10% per year. During the past 3 years, the average Revenue Per Share Growth Rate was 0.30% per year. During the past 5 years, the average Revenue Per Share Growth Rate was 1.00% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get other companies' revenue growth rate.

The historical rank and industry rank for Feng Chi Biotech's Revenue per Share or its related term are showing as below:

ROCO:6744' s 3-Year Revenue Growth Rate Range Over the Past 10 Years
Min: -5.1 Med: 1.1 Max: 6.2
Current: 0.3

During the past 8 years, Feng Chi Biotech's highest 3-Year average Revenue Per Share Growth Rate was 6.20% per year. The lowest was -5.10% per year. And the median was 1.10% per year.

ROCO:6744's 3-Year Revenue Growth Rate is ranked worse than
55.71% of 779 companies
in the Biotechnology industry
Industry Median: 3.6 vs ROCO:6744: 0.30

Feng Chi Biotech Revenue per Share Historical Data

The historical data trend for Feng Chi Biotech's Revenue per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Feng Chi Biotech Revenue per Share Chart

Feng Chi Biotech Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Revenue per Share

Get a 7-Day Free Trial

11.64

11.58

11.81

12.58

11.68

Feng Chi Biotech Semi-Annual Data
	Dec16	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Revenue per Share	Get a 7-Day Free Trial									5.35	6.75	5.81	6.12	5.57

Competitive Comparison of Feng Chi Biotech's Revenue per Share

For the Biotechnology subindustry, Feng Chi Biotech's PS Ratio, along with its competitors' market caps and PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Feng Chi Biotech's PS Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Feng Chi Biotech's PS Ratio distribution charts can be found below:

* The bar in red indicates where Feng Chi Biotech's PS Ratio falls into.

Feng Chi Biotech Revenue per Share Calculation

Revenue per Share is the amount of Revenue per outstanding share of the company's stock.

Also referred as sales, revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top.

Feng Chi Biotech's Revenue Per Share for the fiscal year that ended in Dec. 2023 is calculated as

Revenue Per Share (A: Dec. 2023 )	=	Revenue (A: Dec. 2023 )	/	Shares Outstanding (Diluted Average) (A: Dec. 2023 )
	=	180.578	/	15.458
	=	11.68

Feng Chi Biotech's Revenue Per Share for the quarter that ended in Dec. 2023 is calculated as

Revenue Per Share (Q: Dec. 2023 )	=	Revenue (Q: Dec. 2023 )	/	Shares Outstanding (Diluted Average) (Q: Dec. 2023 )
	=	86.225	/	15.490
	=	5.57

Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was NT$11.68

Feng Chi Biotech (ROCO:6744) Revenue per Share Explanation

In ranking the predictability, companies with more consistent revenue and earnings growth are ranked high with predictability.

Peter Lynch categorized companies according to their revenue growth:

Slow Grower: Inflation < 10-Year Revenue Growth Rate < 10%:
Stalwart: 10% < 10-Year Revenue Growth Rate < 20%:
Fast Grower: 10-Year Revenue Growth Rate > 20%:

His favorite companies are stalwart, those growing between 10-20% a year.

Companies in cyclical industries may see their revenue fluctuate wildly in good years and bad years.

Be Aware

Revenue can be manipulated by changing the way how revenue is booked. Companies may book sales before the payment is received, or before the revenue is fully earned. These will be added to balance sheet items such as account payable or account receivables.

Feng Chi Biotech Revenue per Share Related Terms

Thank you for viewing the detailed overview of Feng Chi Biotech's Revenue per Share provided by GuruFocus.com. Please click on the following links to see related term pages.

Feng Chi Biotech (ROCO:6744) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Feng Chi Biotech Corp (ROCO:6744) » Definitions » Revenue per Share

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 5, Shaoxing North Street, 5th Floor-1, Zhongzheng District, Taipei City, TWN, 100

Website

http://www.fcbiotech.com.tw

Feng Chi Biotech Corp provide promotion and support for clinical testing and molecular genetic medicine research related technologies. The company's products and services include clinical testing, food testing, newborn screening, prenatal screening, iron stomach, interscience, and colony counting.

Feng Chi Biotech (ROCO:6744) Headlines

No Headlines